Brief: Rua Bioscience Received Narcotic License For Distribution And Marketing
28/06/2022 02:27
June 28 (Reuters) - Rua Bioscience RUA.NZ :
* RECEIVED NARCOTIC LICENSE FOR DISTRIBUTION AND MARKETING
OF ITS
FIRST PRODUCT FOR GERMAN MEDICINAL CANNABIS MARKET
Further company coverage: RUA.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth